Viatris Inc

Common Name
Viatris
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
30,000
Ticker
VTRS
Exchange
NASDAQ/NGS
Description
Viatris Inc. is a global healthcare company that produces and markets a wide range of pharmaceutical products. Emerging from the merger between Mylan and Upjohn, a division of Pfizer, Viatris strives ...

Viatris's Financial Statements Preview

Below are the financial statements of Viatris, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
734.8a
991.9a
Accounts receivable, net
3,221.3a
3,700.4a
Inventories
3,854.1a
3,469.7a
Prepaid expenses and other current assets
1,710.5a
2,028.1a
Assets held for sale
0a
2,786a
Total current assets
9,520.7a
12,976.1a
Property, plant and equipment, net
2,666.1a
2,759.6a
Intangible assets, net
17,070.9a
19,181.1a
Goodwill
9,133.3a
9,867.1a
Deferred income tax benefit
753a
692.9a
Other assets
2,356.9a
2,208.7a
Total assets
41,500.9a
47,685.5a
Liabilities
Current liabilities
Accounts payable
1,853.7a
1,938.2a
Income taxes payable
192.7a
226.8a
Current portion of long-term debt and other long-term obligations
8.3a
1,943.4a
Liabilities held for sale
0a
275.1a
Other current liabilities
3,724.7a
3,393.9a
Total current liabilities
5,779.4a
7,777.4a
Long-term debt
14,038.9a
16,188.1a
Deferred income tax liability
1,107.9a
1,735.7a
Other long-term obligations
1,939.2a
1,516.9a
Total liabilities
22,865.4a
27,218.1a
Equity
Viatris Inc. shareholders’ equity
Common stock
12.3a
12.2a
Additional paid-in capital
18,921.6a
18,814.7a
Retained earnings
3,418.8a
4,639.7a
Accumulated other comprehensive loss
-3,212.9a
-2,747.4a
Less: treasury stock - at cost
504.3a
251.8a
Total equity
18,635.5a
20,467.4a
Total liabilities and equity
41,500.9a
47,685.5a
Download Data

Verified Sources Behind Viatris’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Viatris’s data sources below and access millions more through our Disclosure Search.

a. Viatris's 10-K 2024
a. Viatris's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?